Form 4: Nutex Health COO Joshua DeTillio Acquires 20,000 Shares of Common Stock
SEC Form 4 Filing
Nutex Health's Chief Operating Officer, Joshua DeTillio, recently purchased 20,000 shares of the company's common stock at an average price of $0.54 per share.
Summary
- On June 12, 2024, Joshua DeTillio, the Chief Operating Officer of Nutex Health, Inc. (NUTX), acquired 20,000 shares of common stock.
- The shares were purchased at a weighted average price of $0.54 per share, with individual transaction prices ranging from $0.5352 to $0.5353.
- Following the transaction, DeTillio directly owns 29,333 shares of Nutex Health, Inc.
- The shares are held in a joint account with his spouse with rights of survivorship.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a key executive is generally a good sign, but the scale of the purchase is not large enough to indicate a strong positive sentiment.
Positives
- The COO's purchase of company stock may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company insider believes the stock is undervalued or that the company's prospects are strong. However, it's just one data point and should be considered alongside other factors when evaluating a stock.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of stock acquisition by Joshua DeTillio |
| 06/13/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.